OTCMKTS:BICX - Biocorrx Stock Price, News & Analysis

$3.17
-0.33 (-9.43 %)
(As of 09/15/2019 06:17 AM ET)
Today's Range
$3.15
Now: $3.17
$3.20
50-Day Range
$3.15
MA: $3.58
$3.99
52-Week Range
$3.10
Now: $3.17
$13.94
Volume6,513 shs
Average Volume1,632 shs
Market Capitalization$9.70 million
P/E RatioN/A
Dividend YieldN/A
Beta1.11
BioCorRx, Inc. engages in the provision of alcoholism and opioid addiction treatment. It offers treatment philosophy that combines medical intervention and a proprietary cognitive behavioral therapy program specifically tailored for the treatment of alcoholism and other substance abuse addictions for those receiving long-term naltrexone treatment. It also engages in the research and development of sustained release naltrexone products for the treatment of addiction and other possible disorders. The company was founded by Neil Terrence Muller and George O'Neill on January 28, 2008 and is headquartered in Anaheim, CA.

Industry, Sector and Symbol

Industry Specialty outpatient clinics, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:BICX
CUSIPN/A
Phone714-462-4880

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$380,000.00
Book Value($2.20) per share

Profitability

Net Income$-6,510,000.00
Net Margins-2,994.06%

Miscellaneous

EmployeesN/A
Market Cap$9.70 million
Next Earnings Date11/13/2019 (Estimated)
OptionableNot Optionable

Receive BICX News and Ratings via Email

Sign-up to receive the latest news and ratings for BICX and its competitors with MarketBeat's FREE daily newsletter.


Biocorrx (OTCMKTS:BICX) Frequently Asked Questions

What is Biocorrx's stock symbol?

Biocorrx trades on the OTCMKTS under the ticker symbol "BICX."

How were Biocorrx's earnings last quarter?

Biocorrx Inc (OTCMKTS:BICX) posted its quarterly earnings data on Thursday, November, 17th. The company reported ($0.02) earnings per share for the quarter. The business earned $0.17 million during the quarter. View Biocorrx's Earnings History.

When is Biocorrx's next earnings date?

Biocorrx is scheduled to release their next quarterly earnings announcement on Wednesday, November 13th 2019. View Earnings Estimates for Biocorrx.

Has Biocorrx been receiving favorable news coverage?

Headlines about BICX stock have been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Biocorrx earned a coverage optimism score of 0.9 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 1.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for Biocorrx.

Who are some of Biocorrx's key competitors?

Some companies that are related to Biocorrx include Acadia Healthcare (ACHC), BioTelemetry (BEAT), Hanger (HNGR), IMAC (IMAC) and AAC (AAC).

What other stocks do shareholders of Biocorrx own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Biocorrx investors own include Mondi (MNDI), Alkermes (ALKS), Cronos Group (CRON), Cytori Therapeutics (CYTX), Editas Medicine (EDIT), ImmunoGen (IMGN), Intel (INTC), Netflix (NFLX), Nektar Therapeutics (NKTR) and SS&C Technologies (SSNC).

Who are Biocorrx's key executives?

Biocorrx's management team includes the folowing people:
  • Brady James Granier, President Chief Executive Officer & Director
  • Lourdes Felix, Director, Chief Operating & Financial Officer
  • Kenneth Orbeck, Medical Director
  • Balbir S. Brar, Senior Vice President-Drug Development

How do I buy shares of Biocorrx?

Shares of BICX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Biocorrx's stock price today?

One share of BICX stock can currently be purchased for approximately $3.17.

How big of a company is Biocorrx?

Biocorrx has a market capitalization of $9.70 million and generates $380,000.00 in revenue each year. View Additional Information About Biocorrx.

What is Biocorrx's official website?

The official website for Biocorrx is http://www.biocorrx.com/.

How can I contact Biocorrx?

Biocorrx's mailing address is 2390 EAST ORANGEWOOD AVENUE SUITE 575, ANAHEIM CA, 92806. The company can be reached via phone at 714-462-4880 or via email at [email protected]


MarketBeat Community Rating for Biocorrx (OTCMKTS BICX)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  61 (Vote Outperform)
Underperform Votes:  57 (Vote Underperform)
Total Votes:  118
MarketBeat's community ratings are surveys of what our community members think about Biocorrx and other stocks. Vote "Outperform" if you believe BICX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BICX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel